-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Upgrades Solventum to Buy, Announces $95 Price Target

Benzinga·07/28/2026 18:51:00
語音播報
UBS analyst Kevin Caliendo upgrades Solventum (NYSE:SOLV) from Neutral to Buy and announces $95 price target.